Comprehensive Genomic Profiling of Relapsed and Refractory Choroid Plexus Tumors of the Central Nervous System

被引：0

作者：

Galbraith, Kristyn M. ^{[1
]}

Ramkissoon, Shakti ^{[2
]}

Gay, Laurie ^{[3
]}

Elvin, Julia A. ^{[4
]}

Suh, James ^{[5
]}

Severson, Eric ^{[5
]}

Daniel, Sugganth ^{[2
]}

Ali, Siraj

Schrock, Alexa B. ^{[3
]}

Chung, Jon

Miller, Vincent A. ^{[2
]}

Stephens, Philip M. ^{[2
]}

Ross, Jeffrey S. ^{[2
]}

Corona, Robert ^{[1
]}

机构：

[1] SUNY Upstate Med Univ, Syracuse, NY 13210 USA

[2] Fdn Med, Morrisville, NC USA

[3] Fdn Med, Cambridge, MA USA

[4] Fdn Med Inc, Cambridge, MA USA

[5] Fdn Med Inc, Morrisville, NC USA

来源：

MODERN PATHOLOGY | 2018年 / 31卷

关键词：

D O I：

暂无

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

1819

引用

页码：657 / 657

页数：1

共 50 条

[21] Integrated diagnosis and therapeutic decision of pediatric nervous system tumors using a comprehensive genomic profiling test
Azevedo, A.
Roque, R.
Passos, J.
Nunes, S.
Migueis, J.
Faria, C.
Sagarribay, A.
Serpa, A.
Roque, L.
Mafra, M.
Salgado, D.
NEURO-ONCOLOGY, 2022, 24
[22] Clinical utility of DNA methylation profiling for choroid plexus tumors
Yeo, Kee Kiat
Macrae, Cassie B.
Gampel, Bradley
Ahrendsen, Jared T.
Lidov, Hart
Wright, Karen D.
Chi, Susan
Fehnel, Katie
Baird, Lissa
Clymer, Jessica
Aldape, Kenneth
Alexandrescu, Sanda
NEURO-ONCOLOGY ADVANCES, 2024, 6 (01)
[23] Targeting choroid plexus epithelia and ventricular ependyma for drug delivery to the central nervous system
Ana Maria Gonzalez
Wendy E Leadbeater
Michael Burg
Karen Sims
Tetsuya Terasaki
Conrad E Johanson
Edward G Stopa
Brian P Eliceiri
Andrew Baird
BMC Neuroscience, 12
[24] Targeting choroid plexus epithelia and ventricular ependyma for drug delivery to the central nervous system
Maria Gonzalez, Ana
Leadbeater, Wendy E.
Burg, Michael
Sims, Karen
Terasaki, Tetsuya
Johanson, Conrad E.
Stopa, Edward G.
Eliceiri, Brian P.
Baird, Andrew
BMC NEUROSCIENCE, 2011, 12
[25] The choroid plexus is modulated by various peripheral stimuli: implications to diseases of the central nervous system
Marques, Fernanda
Sousa, Joao C.
FRONTIERS IN CELLULAR NEUROSCIENCE, 2015, 9
[26] Therapeutic management of refractory or relapsed primary central nervous system lymphomas
Reni, M
Ferreri, AJM
ANNALS OF HEMATOLOGY, 2001, 80 : B113 - B117
[27] A relapsed/refractory multiple myeloma patient with central nervous system involvement
Cifttciler, R.
Ayar, S.
Susesi, K.
Aksu, S.
Buyukasik, Y.
LEUKEMIA RESEARCH, 2019, 85 : S43 - S43
[28] Ibrutinib Therapy in Relapsed/Refractory Primary Central Nervous System Lymphomas
Guven, Serkan
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S458 - S459
[29] Pemetrexed in the treatment of relapsed/refractory primary central nervous system lymphoma
Raizer, Jeffrey J.
Rademaker, Alfred
Evens, Andrew M.
Rice, Laurie
Schwartz, Margaret
Chandler, James P.
Getch, Christopher C.
Tellez, Claudia
Grimm, Sean A.
CANCER, 2012, 118 (15) : 3743 - 3748
[30] Management of refractory or relapsed primary central nervous system lymphoma (Review)
Yamanaka, Ryuya
MOLECULAR MEDICINE REPORTS, 2009, 2 (06) : 879 - 885

← 1 2 3 4 5 →